Not all patients who share a certain organ involvement can be treated with the same medicine at the same dose. In this piece, Foundation Medical Director Dr. Joan Merrill argues that improved classification of lupus can lead to better treatment.
Lupus Foundation of America supported study demonstrates that blocking STAT5 reduces the production of CD154 by half.
Additional data from the CDC National Lupus Patient Registry project demonstrates that lupus is a widespread disease with a significant impact.
Although the overall risk is small, children born to mothers with lupus may have a higher risk of autism spectrum disorders than children born to mothers without the disease, according to the results of a study presented this week at the American College of Rheumatology Annual Scientific Meeting in San Diego.
Photosensitivity or abnormal light sensitivity is very complex and is a major symptom of lupus. Now, a new, small study sheds more light on photosensitivity among people with lupus. Learn more.
A team of lupus researchers has identified a potential new biomarker that may be helpful in determining whether a person with lupus is at risk for developing organ damage.
The researchers hoped to learn about the genetic contributions to lupus susceptibility and how this might relate to specific lupus-related phenotypes, such as the presence of specific autoantibodies.
The researchers hoped to learn about the relationship among hsCRP, lupus disease activity, and the risk of cardiovascular disease in individuals with lupus.